Mj. Clark et al., OPIOID EFFICACY IN A C6 GLIOMA CELL-LINE STABLY EXPRESSING THE DELTA-OPIOID RECEPTOR, The Journal of pharmacology and experimental therapeutics, 283(2), 1997, pp. 501-510
A C6 glioma cell line stably transfected with the rat delta opioid rec
eptor (C6 delta) was used to characterize receptor binding and G prote
in activation by both peptide and nonpeptide delta opioid ligands. The
ligand binding affinities for [H-3]naltrindole and [H-3]Cl-[D-Pen(2),
D-Pen(5)]enkephalin (DPDPE) were similar to those observed in monkey b
rain membranes. The nonpeptide agonists, BW373U86 and SNC80, as well a
s peptide agonist [D-Ser(2),L-Leu(5)]enkephalyl-Thr maximally stimulat
ed [S-35]GTP gamma S binding by 640, 654 and 576%, respectively, over
basal. The peptide agonists, DPDPE and deltorphin II, both stimulated
[S-35]GTP gamma S binding by 375%. Etorphine, diprenorphine, oxymorphi
ndole and 7-spiroindanyloxymorphone were also partial agonists in this
assay, although they were less efficacious than deltorphin II. Stimul
ation of [S-35]GTP gamma S binding by agonists was blocked completely
by pertussis toxin pretreatment. Both delta-1 and delta-2 selective an
tagonists 7-benzylidenenaltrexone and a benzofuran analog of naltrindo
le displayed high affinity for the cloned receptor (0.04 and 0.08 nM)
and antagonized the stimulation of [S-35]GTP gamma S binding by BW373U
86 and DPDPE with similar potencies. Other evidence suggesting the lac
k of receptor subtypes includes the finding that stimulation of [S-35]
GTP gamma S binding by receptor subtype selective ligands DPDPE and de
ltorphin II was not additive. BW373U86, SNC80 and DPDPE maximally inhi
bited forskolin-stimulated adenylyl cyclase. These cells highly expres
s a homogeneous population of delta opioid receptor that couple to inh
ibitory G(o)/G(i) proteins. Ligand affinity for the delta opioid recep
tor correlates with ligand EC50 values for stimulation of [S-35]GTP ga
mma S binding.